Abstract
To date, the identification of individuals at risk of suicide is based on subjective reports. Given that individuals at risk often do not disclose their suicidal thoughts, the introduction of objective measures – such as biomarkers – of suicide risk might help in predicting which individuals will eventually die by suicide. Biomarkers have a potentially relevant role in the prediction of suicide, as an adjunct to, rather than a substitute for, current clinical practice. Within the context of the stress-diathesis model of suicidal behavior, the most relevant biomarkers for estimating suicide risk are non-suppression in the dexamethasone suppression test (DST) – a biomarker of stress – and reduced concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF), a biomarker of diathesis. Given the multi-determined nature of suicide, a combination of biological, clinical, neuropsychological, and neuroimaging factors might yield a better estimate of suicide risk than using biomarkers alone and help overcome current limitations in the prediction of suicide.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asberg M, Traskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:1193–1197
Banerjee R, Ghosh AK, Ghosh B, Bhattacharyya S, Mondal AC (2013) Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: an analysis in human postmortem brain. Clin Med Insights Pathol 6:1–11
Bayard-Burfield L, Alling C, Blennow K, Jonsson S, Traskman-Bendz L (1996) Impairment of the blood-CSF barrier in suicide attempters. Eur Neuropsychopharmacol 6:195–199
Blasco-Fontecilla H, Lopez-Castroman J, Giner L, Baca-Garcia E, Oquendo MA (2013) Predicting suicidal behavior: are we really that far along? Comment on “Discovery and validation of blood biomarkers for suicidality”. Curr Psychiatry Rep 15:424
Braquehais MD, Picouto MD, Casas M, Sher L (2012) Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide. World J Pediatr 8:197–206
Brower V (2011) Biomarkers: portents of malignancy. Nature 471:S19–S21
Coryell W, Schlesser M (2001) The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158:748–753
Coryell W, Schlesser M (2007) Combined biological tests for suicide prediction. Psychiatry Res 150:187–191
Davis AT, Schrueder C (1990) The prediction of suicide. Med J Aust 153:552–554
Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127
Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:804–815
Falcone T, Fazio V, Lee C, Simon B, Franco K, Marchi N, Janigro D (2010) Serum S100B: a potential biomarker for suicidality in adolescents? PLoS One 5:e11089
Fawcett J, Busch KA, Jacobs D, Kravitz HM, Fogg L (1997) Suicide: a four-pathway clinical-biochemical model. Ann N Y Acad Sci 836:1981
Gerszten RE, Wang TJ (2008) The search for new cardiovascular biomarkers. Nature 451:949–952
Golier JA, Marzuk PM, Leon AC, Weiner C, Tardiff K (1995) Low serum cholesterol level and attempted suicide. Am J Psychiatry 152:419–423
Jokinen J, Carlborg A, Martensson B, Forslund K, Nordstrom AL, Nordstrom P (2007) DST non-suppression predicts suicide after attempted suicide. Psychiatry Res 150:297–303
Jokinen J, Martensson B, Nordstrom AL, Nordstrom P (2008) CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters? J Affect Disord 105:241–245
Jokinen J, Nordstrom AL, Nordstrom P (2009) Cerebrospinal fluid monoamine metabolites and suicide. Nord J Psychiatry 63:276–279
Jollant F, Lawrence NL, Olie E, Guillaume S, Courtet P (2011) The suicidal mind and brain: a review of neuropsychological and neuroimaging studies. World J Biol Psychiatry 12:319–339
Jones R (2010) Biomarkers: casting the net wide. Nature 466:S11–S12
Kim YK, Myint AM (2004) Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 81:161–166
Lee BH, Kim YK (2011) Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35:842–847
Lee JM, Han JJ, Altwerger G, Kohn EC (2011) Proteomics and biomarkers in clinical trials for drug development. J Proteomics 74:2632–2641
Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, Winiger E, Bhosrekar S, Shankar G, Radel M, Bellanger E, Duckworth H, Olesek K, Vergo J, Schweitzer R, Yard M, Ballew A, Shekhar A, Sandusky GE, Schork NJ, Kurian SM, Salomon DR, Niculescu AB 3rd (2013) Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry 18:1249–1264
Lester D (1995) The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 28:45–50
Lindberg G, Rastam L, Gullberg B, Eklund GA (1992) Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 305:277–279
Mann JJ, Currier D (2007) A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch Suicide Res 11:3–16
Mann JJ, Waternaux C, Haas GL, Malone KM (1999) Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 156:181–189
Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP (2006) Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 9:465–474
McIntyre RS, Muzina DJ, Kemp DE, Blank D, Woldeyohannes HO, Lofchy J, Soczynska JK, Banik S, Konarski JZ (2008) Bipolar disorder and suicide: research synthesis and clinical translation. Curr Psychiatry Rep 10:66–72
Meijer OC, De Kloet ER (1998) Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 12:1–20
Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME, Mann JJ (2014) Toward a biosignature for suicide. Am J Psychiatry 171:1259–1277
Papadopoulou A, Markianos M, Christodoulou C, Lykouras L (2013) Plasma total cholesterol in psychiatric patients after a suicide attempt and in follow-up. J Affect Disord 148:440–443
Poudel-Tandukar K, Nanri A, Iwasaki M, Mizoue T, Matsushita Y, Takahashi Y, Noda M, Inoue M, Tsugane S (2011) Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women – the Japan Public Health Center-based (JPHC) prospective study. J Affect Disord 129:282–288
Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA (2006) A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord 8:543–550
Singh I, Rose N (2009) Biomarkers in psychiatry. Nature 460:202–207
Smith EG, Kim HM, Ganoczy D, Stano C, Pfeiffer PN, Valenstein M (2013) Suicide risk assessment received prior to suicide death by Veterans Health Administration patients with a history of depression. J Clin Psychiatry 74:226–232
Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ (2006) Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 163:1100–1102
Sunnqvist C, Westrin A, Traskman-Bendz L (2008) Suicide attempters: biological stressmarkers and adverse life events. Eur Arch Psychiatry Clin Neurosci 258:456–462
Traskman L, Asberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631–636
Tsai AC, Lucas M, Okereke OI, O’Reilly EJ, Mirzaei F, Kawachi I, Ascherio A, Willett WC (2014) Suicide mortality in relation to dietary intake of n-3 and n-6 polyunsaturated fatty acids and fish: equivocal findings from 3 large US cohort studies. Am J Epidemiol 179:1458–1466
Zhang L, Su TP, Choi K, Maree W, Li CT, Chung MY, Chen YS, Bai YM, Chou YH, Barker JL, Barrett JE, Li XX, Li H, Benedek DM, Ursano R (2011) P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J Psychiatr Res 45:435–441
Zureik M, Courbon D, Ducimetiere P (1996) Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ 313:649–651
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Blasco-Fontecilla, H., Oquendo, M.A. (2016). Biomarkers of Suicide: Predicting the Predictable?. In: Courtet, P. (eds) Understanding Suicide. Springer, Cham. https://doi.org/10.1007/978-3-319-26282-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-26282-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26280-2
Online ISBN: 978-3-319-26282-6
eBook Packages: MedicineMedicine (R0)